Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm

BACKGROUND: Four randomized controlled trials have demonstrated the short-term efficacy and safety of transoral esophagogastric fundoplication (TF) performed with the EsophyX(®) device in eliminating troublesome gastroesophageal reflux disease (GERD) symptoms in well-selected patient populations. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Trad, Karim S., Fox, Mark A., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Barnes, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443856/
https://www.ncbi.nlm.nih.gov/pubmed/27655380
http://dx.doi.org/10.1007/s00464-016-5252-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443856/
https://www.ncbi.nlm.nih.gov/pubmed/27655380
http://dx.doi.org/10.1007/s00464-016-5252-8

Ejemplares similares